Form 8-K - Current report:
SEC Accession No. 0001664710-25-000002
Filing Date
2025-01-10
Accepted
2025-01-10 08:00:53
Documents
52
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kros-20250110.htm   iXBRL 8-K 37191
2 EX-99.1 corpdeckjan2025.htm EX-99.1 55708
6 corpdeckjan2025001.jpg GRAPHIC 79103
7 corpdeckjan2025002.jpg GRAPHIC 263127
8 corpdeckjan2025003.jpg GRAPHIC 154953
9 corpdeckjan2025004.jpg GRAPHIC 102518
10 corpdeckjan2025005.jpg GRAPHIC 165595
11 corpdeckjan2025006.jpg GRAPHIC 169233
12 corpdeckjan2025007.jpg GRAPHIC 76736
13 corpdeckjan2025008.jpg GRAPHIC 153135
14 corpdeckjan2025009.jpg GRAPHIC 92484
15 corpdeckjan2025010.jpg GRAPHIC 181180
16 corpdeckjan2025011.jpg GRAPHIC 168086
17 corpdeckjan2025012.jpg GRAPHIC 116381
18 corpdeckjan2025013.jpg GRAPHIC 61215
19 corpdeckjan2025014.jpg GRAPHIC 173896
20 corpdeckjan2025015.jpg GRAPHIC 176141
21 corpdeckjan2025016.jpg GRAPHIC 157409
22 corpdeckjan2025017.jpg GRAPHIC 136064
23 corpdeckjan2025018.jpg GRAPHIC 104275
24 corpdeckjan2025019.jpg GRAPHIC 141942
25 corpdeckjan2025020.jpg GRAPHIC 147890
26 corpdeckjan2025021.jpg GRAPHIC 116547
27 corpdeckjan2025022.jpg GRAPHIC 114342
28 corpdeckjan2025023.jpg GRAPHIC 86386
29 corpdeckjan2025024.jpg GRAPHIC 73884
30 corpdeckjan2025025.jpg GRAPHIC 100833
31 corpdeckjan2025026.jpg GRAPHIC 149746
32 corpdeckjan2025027.jpg GRAPHIC 154597
33 corpdeckjan2025028.jpg GRAPHIC 148225
34 corpdeckjan2025029.jpg GRAPHIC 157775
35 corpdeckjan2025030.jpg GRAPHIC 165051
36 corpdeckjan2025031.jpg GRAPHIC 111008
37 corpdeckjan2025032.jpg GRAPHIC 159849
38 corpdeckjan2025033.jpg GRAPHIC 168995
39 corpdeckjan2025034.jpg GRAPHIC 171128
40 corpdeckjan2025035.jpg GRAPHIC 175976
41 corpdeckjan2025036.jpg GRAPHIC 78618
42 corpdeckjan2025037.jpg GRAPHIC 107689
43 corpdeckjan2025038.jpg GRAPHIC 60222
  Complete submission text file 0001664710-25-000002.txt   7300930

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20250110.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20250110_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20250110_pre.xml EX-101.PRE 13046
54 EXTRACTED XBRL INSTANCE DOCUMENT kros-20250110_htm.xml XML 2823
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 811173868 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39264 | Film No.: 25520502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)